Hematology

Filter

Patient and physician perspectives on shared decisions in CML

October 2025

In this new podcast episode, Lisa Machado, a patient advocate diagnosed with CML in 2008 and clinician and CML expert Jeffrey Lipton, sit…

miRNA Signatures as Biomarkers for Haemophilic Arthropathy: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, miRNA signatures could serve as biomarkers for hemophilic arthropathy.

Emerging Risks of Spinal Stenosis in Older People with Haemophilia: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, spinal stenosis is increasingly common in aging hemophilia patients.

Nurse-Led Education for Female Haemophilia Carriers: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, nurse-led education empowers female hemophilia carriers across life stages.

Maintaining Healthy Weight Reduces Risk of Multiple Myeloma

A recent study found that patients with monoclonal gammopathy of undetermined significance who maintain a healthy weight have a lower risk of progression to multiple myeloma.

Frederik-Schjesvold

Hema Now: Episode 10: Shaping the Future of Myeloma

Fredrik Schjesvold, Head of the Oslo Myeloma Center, Oslo University Hospital, and Head of the Norwegian myeloma association joins the show.

Increased Cancer Risk After Cerebral Venous Thrombosis

CVT patients face a significantly higher cancer risk, especially in the first year and up to 10 years after diagnosis.

Increased Risk of Skin Cancer After Blood or Marrow Transplant

BMT survivors face a higher risk of skin cancer, with age, graft-vs-host disease, and treatment influencing outcomes.

Immune Checkpoint Inhibitor Before Allogeneic Transplant Boosts Survival in Hodgkin Lymphoma

ICI treatment before transplant enhances survival in relapsed Hodgkin lymphoma, though it increases the risk of acute GVHD.

Loading posts...

« Previous 1 … 19 20 21 22 23 … 95 Next »